NCT00617695View on ClinicalTrials.gov

Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

October 31, 2004

Conditions
Migraine
Interventions
DRUG

Zolmitriptan

5mg nasal spray

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Impax Laboratories, LLC

INDUSTRY

NCT00617695 - Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents | Biotech Hunter | Biotech Hunter